Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Traphaco is a leading pharmaceutical company in Vietnam, recognized as a pioneer in the modernization of traditional herbal medicines. The company operates a vertically integrated business model that encompasses the cultivation of GACP-compliant medicinal plants, state-of-the-art GMP manufacturing facilities, and an extensive nationwide distribution network. Traphaco's product portfolio is anchored by market-leading brands such as Boganic for liver health and Cebraton for cognitive function, alongside a growing range of modern western pharmaceuticals. By integrating advanced technology and 'Pharma 4.0' standards into its production processes, Traphaco maintains a dominant position in the Vietnamese domestic market while expanding its presence in the broader Southeast Asian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TRA.